Because of “unexplained illness” in understanding, Johnson and Johnson delays COVID-19 immunization concentrate

Johnson and Johnson declared Monday has stopped an investigation of its COVID-19 immunization because of an “unexplained illness” in an examination member. Situational mindfulness: “This is the normal process. This doesn’t mean the illness is related to the vaccine. But these things need to get investigated by an independent committee. Happens in many Phase III trials,” Florian Krammer, a teacher at School of Medicine at Mount Sinai, noted on Twitter. The AstraZeneca COVID-19 antibody study was required to be postponed toward the beginning of September after an investigation member in…

Read More